Dr. A Lindsay Frazier, MD

Save

Pediatric Hematology & Oncology | Female

Dr. A Lindsay Frazier, MD
Dr. A. Lindsay Frazier's clinical focus within pediatric oncology is germ cell tumors (GCT). Her involvement in germ cell tumors ranges from clinical trials, to biology and to epidemiology. She has served on the steering committee of the Childrens' Oncology Group's (COG) germ cell committee since 1996 and assumed leadership of the committee in 2007 which entails oversight of all current protocols and development of the strategic initiatives for future protocols across the spectrum of disease from low risk to high risk to salvage therapies.. She has served as the Chair of the COG protocol for low/intermediate risk germ cell tumors protocol (AGCT0132), Vice-Chair of the COG protocol for relapsed germ cell tumors and for high risk germ cell tumors. She has authored numerous papers and chapters on pediatric germ cell tumors and is currently editing a book for Springer of Pediatric Germ Cell Tumors. Dr. Frazier led the formation of an international group of germ cell tumor specialists from the United States and United Kingdom, "MaGIC—the Malignant Germ Cell International Collaboration" that has merged their clinical trial data from the past 25 years to create a more comprehensive risk classification system now serving as the basis for next generation of international clinical trials currently under review. MaGIC has recently been expanded to include the clinical trial data of the Gynecologic Oncology Group (ovarian GCT) and the Medical Research Council (testicular cancer) so that this risk classification can be developed spanning the adolescent-young adult boundaries. The clinical data can also now be linked to banked biologic specimens. Drs. Frazier and Amatruda have already successfully collaborated on several translational projects utilizing these datasets. Dr. Frazier also holds an appointment in epidemiology at the Harvard School of Public Health and until 2011 served as the co-director of the Growing Up Today Study, a national cohort study of 27,000 offspring of the women in the Nurses Health Study. Her epidemiologic expertise is of use in the design of the design and interpretation of the data generated by this trial.

Learn about this doctor

Dr. Frazier's Experience

0ExperienceMatch
Experience Match

See how Dr. Frazier's experience matches your preferences.

1
Specialties

For the best healthcare for your needs, choose a doctor who specializes in your medical condition.

4
Conditions Treated

Check to see that this provider treats your medical condition.

4
Procedures Performed

Check to see that this provider performs the procedure that you need.

Background Check

Check to see if your provider has any malpractices, board actions, or sanctions.

Education

Learn more about where this provider went to medical school, residency, and more.

Languages Spoken

Check to see what languages this provider and/or staff speak.

Memberships & Professional Affiliations

View memberships and affiliations associated with this provider.

Visiting Dr. Frazier

Dr. Frazier accepts 1 insurance carrier

Dr. Frazier is now accepting new patients

Affiliated Hospitals

Hospital Quality
Check out the quality of care at the 2 hospitals where Dr. Frazier has admitting privileges.

Dr. Frazier's Reviews

Help millions of people find the right doctor. Share your experience today!
Are you Dr. Frazier?
Make it easy for patients to share their feedback. Also manage your personalized profile!

Compare Dr. Frazier

Compare this Doctor
View other doctors with similar experience to find the right doctor for you.
View all 10 matches

Dr. Frazier says...

Dr. A. Lindsay Frazier's clinical focus within pediatric oncology is germ cell tumors (GCT). Her involvement in germ cell tumors ranges from clinical trials, to biology and to epidemiology. She has served on the steering committee of the Childrens' Oncology Group's (COG) germ cell committee since 1996 and assumed leadership of the committee in 2007 which entails oversight of all current protocols and development of the strategic initiatives for future protocols across the spectrum of disease from low risk to high risk to salvage therapies.. She has served as the Chair of the COG protocol for low/intermediate risk germ cell tumors protocol (AGCT0132), Vice-Chair of the COG protocol for relapsed germ cell tumors and for high risk germ cell tumors. She has authored numerous papers and chapters on pediatric germ cell tumors and is currently editing a book for Springer of Pediatric Germ Cell Tumors.

Dr. Frazier led the formation of an international group of germ cell tumor specialists from the United States and United Kingdom, "MaGIC—the Malignant Germ Cell International Collaboration"  that has merged their clinical trial data from the past 25 years to create a more comprehensive risk classification system now serving as the basis for next generation of international clinical trials currently under review. MaGIC has recently been expanded to include the clinical trial data of the Gynecologic Oncology Group (ovarian GCT) and the Medical Research Council (testicular cancer) so that this risk classification can be developed spanning the adolescent-young adult boundaries. The clinical data can also now be linked to banked biologic specimens. Drs. Frazier and Amatruda have already successfully collaborated on several translational projects utilizing these datasets. Dr. Frazier also holds an appointment in epidemiology at the Harvard School of Public Health and until 2011 served as the co-director of the Growing Up Today Study, a national cohort study of 27,000 offspring of the women in the Nurses Health Study. Her epidemiologic expertise is of use in the design of the design and interpretation of the data generated by this trial.

Dr. Frazier's experience matches your search based on the following criteria:

  •  Based on total number of patients treated over the last 12 months
  •  Specializes in Pediatric Hematology & Oncology
  •  No board certification on record with Healthgrades
  •  No malpractice claims found
  •  No sanctions found
  •  No board actions found

Background Check

  • 0
    Malpractice Claims

    No malpractice history found for Massachusetts.

    What is medical malpractice
  • 0
    Sanctions

    No sanctions history found for the years that Healthgrades collects data.

    What is a sanction or disciplinary action
  • 0
    Board Actions

    No board actions found for the years that Healthgrades collects data.

    What are board actions

Conditions Treated

  • Benign Hematologic Problems
  • Germ Cell Tumor
  • Hematologic Problems
  • Pediatric Cancer

Education

  • Medical School
    Dartmouth Medical School

    Graduated in 1984

  • Internship Hospital
    Boston Children's Hospital, Pediatrics

    Completed in 1989

  • Residency Hospital
    Boston Children's Hospital, Pediatrics

    Completed in 1989

Languages Spoken

  • English

Memberships &
Professional Affiliations

Dr. Frazier does not have any memberships or affiliations listed. If you are Dr. Frazier and would like to add memberships or affiliations, please update your free profile.

Specialties

  • Pediatric Hematology & Oncology

Procedures Performed

  • Bone Marrow Biopsy
  • Cancer Prevention
  • Hematologic Disorder Treatment
  • Pediatric Cancer Resection